Clinical Study

Correlation of Interleukin-17-Producing Effector Memory T Cells and CD4+CD25+Foxp3 Regulatory T Cells with the Phosphate Levels in Chronic Hemodialysis Patients

Table 2

Biochemistry and flow cytometry results of subjects (mean ± SD) in the diabetes and nondiabetes groups.

Diabetes groupNondiabetes group

Patients ( )5253
Hemoglobin (g/dL)10.43 ± 1.410.14 ± 1.8
Glucose (mg/dL)155.4 ± 82.398.25 ± 22.6**
Albumin (g/dL)4.02 ± 0.33.90 ± 0.5
Predialysis BUN (mg/dL)60.62 ± 18.557.19 ± 16.8
Predialysis Cre (mg/dL)9.59 ± 2.49.80 ± 2.6
Kt/V1.62 ± 0.31.71 ± 0.3
Uric acid (mg/dL)6.70 ± 1.46.68 ± 1.4
Triglyceride (mg/dL)191.10 ± 137.9130.53 ± 92.3**
Total cholesterol (mg/dL)174.38 ± 42.4170.79 ± 40.9
Alkaline phosphate (IU/L)69.94 ± 30.863.32 ± 22.5
Total calcium (mg/dL)9.43 ± 0.79.38 ± 0.9
Phosphate (mg/dL)4.99 ± 1.65.04 ± 1.9
iPTH (pg/dL)212.12 ± 228.2250.59 ± 286.2
WBC counts (×1000/μL)6.80 ± 1.46.15 ± 1.8*
Lymphocyte count (×1000/μL)1.78 ± 0.51.55 ± 0.7
Th17 cell (%)26.43 ± 10.124.82 ± 10.3
Treg cell (%)8.19 ± 4.48.70 ± 4.2
CRP (mg/dL)0.96 ± 2.00.57 ± 1.0

 * versus the diabetes group ** versus the diabetes group.
Cre: creatinine; iPTH: intact parathyroid hormone; WBC: white blood cell; CRP: C-reactive protein.